medigraphic.com
ISSN 0187-5337 (Print)
Instituto Nacional de Perinatología

2008, Number 4

<< Back Next >>

Perinatol Reprod Hum 2008; 22 (4)

Apnea de la Prematurez

Reyes TR, Cordero GG, Álvarez PIJ

Language: Spanish
References: 27
Page: 279-289
PDF size: 346.02 Kb.


ABSTRACT

Apnea, defined as cessation of breathing resulting in pathological changes in heart rate and oxygen saturation. Although apnea typically results from immaturity of the respiratory control system, it also may be the sign of other diseases or pathologic states that frequently affect preterm infants. This unstable breathing may lead to severe cerebral hypoxia and be life threatening, especially in preterm infants. Many questions on the mechanisms responsible for controlling neonatal apneas remain unresolved. Secondary causes of apnea should be excluded before a diagnosis of apnea of prematurity is made. Methylxanthines and Continuous Positive Airway Pressure are the mainstay treatment of apnea in neonates. Mechanical ventilation is reserved for apnea resistant to above therapy. An update to the management of apnea in neonates has been described in the present review.


REFERENCES

  1. Abu-Shaweesh JM, Martin RJ. Apnea of prematurity: past, present and future. J Arab Neonatal Forum 2005; 2: 63-73.

  2. Poblano A, Márquez A, Hernández G. Apnea in Infants. Indian J Pediatr 2006; 73(12): 1085-8.

  3. Fernández LA, Salinas V, Lázaro M. Tesis: Morbilidad y mortalidad en la unidad de cuidados intensivos neonatales del Instituto Nacional de Perinatología. México, D.F. 2007.

  4. Baird TM, Martin RJ, Abu-Shaweesh JM. Clinical Associations, Treatment, and Outcome of Apnea of Prematurity. Neo Rev 2002; 3(4): 66-70.

  5. Martin RJ, Abu-Shaweesh JM, Baird TM. Pathophysiologic Mechanisms Underlying Apnea of Prematurity. Neo Rev 2002; 3(4): 59-65.

  6. Bathia J. Current Options in the Management of Apnea of Prematurity. Clin Pediatr (Phila) 2000; 39; 327-36.

  7. Janvier A, Khairy M, Kokkotis A, Cormier MC. Apnea Is Associated with Neurodevelopmental Impairment in Very Low Birth Weight Infants. J Perinat 2004; 24: 763-8.

  8. Peter CS, Sprodowski N, Bohnhorst B, Silny J, Poets CF. Gastroesophageal Reflux and Apnea of Prematurity: No Temporal Relationship. Pediatrics 2002; 109: 8-11.

  9. Martin RJ, Abu-Shaweesh JM. Control of Breathing and Neonatal Apnea. Biol Neonate 2005; 87: 288-95.

  10. Widdicombem J, Lee LY. Airway Reflexes, Autonomic Function, and Cardiovascular Responses. Environ Health Perspect 2001; 109(4): 579-84.

  11. Dorion D, Praud JP. The larynx and neonatal apneas. Otolaryngol Head Neck Surg 2003; 128: 463-9

  12. Fewell JE. Protective responses of the newborn to hypoxia. Resp Phys Neurobiol 2005; 149: 243-55.

  13. Osborn DA, Henderson-Smart DJ. Estimulación kinestésica para el tratamiento de la apnea en lactantes prematuros (Revisión Cochrane traducida). En: La Biblioteca Cochrane Plus, 2007 Número 1. Oxford: Update Software Ltd. Disponible en: http:// www.update-software.com. (Traducida de The Cochrane Library, 2007 Issue 1. Chichester, UK: John Wiley & Sons, Ltd.).

  14. Osborn DA, Henderson-Smart DJ. Estimulación quinestésica versus teofilina para la apnea en recién nacidos prematuros (Revisión Cochrane traducida). En: La Biblioteca Cochrane Plus, 2007 Número 1. Oxford: Update Software Ltd. Disponible en: http://www.update-software.com. (Traducida de The Cochrane Library, 2007 Issue 1. Chichester, UK: John Wiley & Sons, Ltd.).

  15. Marlier L, Gaugler C, Messer J. Olfactory Stimulation Prevents Apnea in Premature Newborns. Pediatrics 2005; 115; 83-8.

  16. Gaugler C. Traitement des apnées idiopathiques du prématuré par stimulations sensorielles. Archives de pédiatrie 2007; doi: 10.1016/j.arcped.2007.01.013.

  17. The Underpinnings of Neonatal/Perinatal Medicine. Use of Methylxanthines in the Management of Apneic Attacks in the Newborn. Neo Rev 2003; 4(3): 62-4.

  18. PA Steer, Henderson-Smart DJ. Cafeína versus teofilina para la apnea en neonatos prematuros (Revisión Cochrane traducida). En: La Biblioteca Cochrane Plus, 2007 Número 1. Oxford: Update Software Ltd. Disponible en: http://www.update-software.com. (Traducida de The Cochrane Library, 2007 Issue 1. Chichester, UK: John Wiley & Sons, Ltd.).

  19. Henderson-Smart DJ, Steer PA. Profilaxis con metilxantinas para la prevención de la apnea en recién nacidos prematuros (Revisión Cochrane traducida). En: La Biblioteca Cochrane Plus, 2007 Número 1. Oxford: Update Software Ltd. Disponible en: http://www.update-software.com. (Traducida de The Cochrane Library, 2007 Issue 1. Chichester, UK: John Wiley & Sons, Ltd.).

  20. Henderson-Smart DJ , Steer P. Tratamiento con metilxantinas para la apnea en recién nacidos prematuros (Revisión Cochrane traducida). En: La Biblioteca Cochrane Plus, 2007 Número 1. Oxford: Update Software Ltd. Disponible en: http://www.update-software.com. (Traducida de The Cochrane Library, 2007 Issue 1 Chichester, UK: John Wiley & Sons, Ltd.).

  21. Millara D, Schmidt B. Controversies surrounding xanthine therapy. Seminars in Neonatology 2004;9:239-44.

  22. Poets CF, Darraj S, Bohnhorst B. Effect of Doxopram on Episodes of Apnoea, Bradycardia and Hypoxaemia in Preterm Infants. Biol Neonate 1999; 76: 207-13.

  23. Henderson-Smart DJ, Steer P. Doxapram versus metilxantinas para la apnea en lactantes prematuros (Revisión Cochrane traducida). En: La Biblioteca Cochrane Plus, 2007 Número 1. Oxford: Update Software td. Disponible en: http://www.updatesoftware.com. (Traducida de The Cochrane Library, 2007 Issue 1. Chichester, UK: John Wiley & Sons, Ltd.).

  24. Lin CH, Wang ST, Lin YJ, Yeh TF. Efficacy of Nasal Intermittent Positive Pressure Ventilation in Treating Apnea of Prematurity. Pediatr Pulmonol 1998; 26: 349-53.

  25. Henderson-Smart DJ, Subramaniam P, Davis PG. Presión positiva continua de la vía aérea versus teofilina para la apnea en recién nacidos (Revisión Cochrane traducida). En: La Biblioteca Cochrane Plus, 2007 Número 1. Oxford: Update Software Ltd. Disponible en: http://www.update-software.com. (Traducida de The Cochrane Library, 2007 Issue 1. Chichester, UK: John Wiley & Sons, Ltd.).

  26. Frey B, Shann F. Oxygen administration in infants. Arch Dis Child Fetal Neonatal Ed 2003; 88: 84-8.

  27. Sreenan C, Lemke RP, Hudson-Mason A, H Osiovich. High-Flow Nasal Cannulae in the Management of Apnea of Prematurity: A Comparison With Conventional Nasal Continuous Positive Airway Pressure. Pediatrics 2001; 107; 1081-3.




2020     |     www.medigraphic.com